Presentation Information
[Pj-096-6]Benefit Assessment of the Patient Support Program "Circle" in NMOSD patients using satralizumab
Yuta Kamei1, Chiaki Sugita1, Katsuhisa Yamashita2, Kazuo Fujihara3,4 (1.Drug Safety Division, Chugai Pharmaceutical Co., Ltd., Japan, 2.Medical Affairs Division, Chugai Pharmaceutical Co. Ltd., Japan, 3.Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan)